NewAmsterdam Pharma Company N.V. earnings per share and revenue

NAMS earnings per share for the last quarter are -0.97 USD whereas the estimation was -0.72 USD which accounts for -34.51% surprise. Company revenue for the same period amounts to 12.79 M USD despite the estimated figure of 7.48 M USD. Estimated earnings per share for the next quarter are -0.54 USD, and revenue is expected to reach 1.70 M USD. Also watch annual changes over time to get a bigger picture of NAMS earnings per share and revenue dynamics.